Pulmonary embolism resident survival guide: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) |
Rim Halaby (talk | contribs) |
||
Line 62: | Line 62: | ||
{{familytree | | |JOE| | | | | | | |SIS| | | JOE='''Yes'''|ME=Inconclusive study|SIS='''No'''}} | {{familytree | | |JOE| | | | | | | |SIS| | | JOE='''Yes'''|ME=Inconclusive study|SIS='''No'''}} | ||
{{familytree | | | |!| | | | | | | | | |!| }} | {{familytree | | | |!| | | | | | | | | |!| }} | ||
{{familytree | | |MOM| | | | | | | | SIS | | |MOM='''[[IVC filter]]'''|SIS='''Risk | {{familytree | | |MOM| | | | | | | | SIS | | |MOM='''[[IVC filter]]'''|SIS='''Risk stratification'''}} | ||
{{familytree | | | | | | | | | | | | | |!| }} | {{familytree | | | | | | | | | | | | | |!| }} | ||
{{familytree | | | | | | | |,|-|-|-|-|-|+|-|-|-|.}} | {{familytree | | | | | | | |,|-|-|-|-|-|+|-|-|-|.}} | ||
Line 72: | Line 72: | ||
{{familytree | | | | | | | | | | | | |B3| | |!| |B3='''Assess clinically for evidence of increased severity'''}} | {{familytree | | | | | | | | | | | | |B3| | |!| |B3='''Assess clinically for evidence of increased severity'''}} | ||
{{familytree | | | | | | | | | | | | | |!| | | |!| |}} | {{familytree | | | | | | | | | | | | | |!| | | |!| |}} | ||
{{familytree | | | | | | | | | | | | |B4|-|C4| | |B4='''Evidence of | {{familytree | | | | | | | | | | | | |B4|-|C4| | |B4='''Evidence of shock (SBP <90 mmHg) or respiratory failure''' |C4='''Is [[thrombolytic]] contraindicated?'''}} | ||
{{familytree | | | | | | | | | | | | | | | |,|-|^|-|.| }} | {{familytree | | | | | | | | | | | | | | | |,|-|^|-|.| }} | ||
{{familytree | | | | | | | | | | | | | | |JOE| |SIS|JOE='''Yes'''|ME=Inconclusive study|SIS='''No'''}} | {{familytree | | | | | | | | | | | | | | |JOE| |SIS|JOE='''Yes'''|ME=Inconclusive study|SIS='''No'''}} | ||
{{familytree | | | | | | | | | | | | | | | |!| | | |!| }} | {{familytree | | | | | | | | | | | | | | | |!| | | |!| }} | ||
{{familytree | | | | | | | | | | | | | | |SIS| |B02|SIS='''[[Pulmonary thrombectomy|Surgical emblectomy]]''' or '''[[Pulmonary embolism catheter based interventions|catheter based interventions]]'''|B02='''Hold | {{familytree | | | | | | | | | | | | | | |SIS| |B02|SIS='''[[Pulmonary thrombectomy|Surgical emblectomy]]''' or '''[[Pulmonary embolism catheter based interventions|catheter based interventions]]'''|B02='''Hold [[anticoagulation]], give [[thrombolytics]] then resume [[anticoagulations]]'''}} | ||
{{familytree | | | | | | | | | | | | | | | | | | | |!| | | |}} | {{familytree | | | | | | | | | | | | | | | | | | | |!| | | |}} | ||
{{familytree | | | | | | | | | | | | | | | | | | |SIS|SIS=Patient shows clinical improvement}} | {{familytree | | | | | | | | | | | | | | | | | | |SIS|SIS=Patient shows clinical improvement}} | ||
Line 82: | Line 82: | ||
{{familytree | | | | | | | | | | | | | | | | |JOE| |SIS|JOE='''No'''|ME=Inconclusive study|SIS='''Yes'''}} | {{familytree | | | | | | | | | | | | | | | | |JOE| |SIS|JOE='''No'''|ME=Inconclusive study|SIS='''Yes'''}} | ||
{{familytree | | | | | | | | | | | | | | | | | |!| | | |!| }} | {{familytree | | | | | | | | | | | | | | | | | |!| | | |!| }} | ||
{{familytree | | | | | | | | | | | | | | | | |SIS| |B02|SIS='''[[Pulmonary thrombectomy|Surgical emblectomy]]''' or '''[[Pulmonary embolism catheter based interventions|catheter based interventions]]'''|B02=Continue anticoagulation}} | {{familytree | | | | | | | | | | | | | | | | |SIS| |B02|SIS='''[[Pulmonary thrombectomy|Surgical emblectomy]]''' or '''[[Pulmonary embolism catheter based interventions|catheter based interventions]]'''|B02='''Continue anticoagulation'''}} | ||
{{familytree/end}} | {{familytree/end}} | ||
==References== | ==References== |
Revision as of 14:08, 4 August 2013
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Rim Halaby
For pulmonary embolism smart algorithm click here
Definition
Causes
Life Threatening Causes
Life-threatening causes include conditions which result in death or permanent disability within 24 hours if left untreated.
Common Causes
Management
Step 1: Establish The Diagnosis Of Pulmonary Embolism
In hospitals that have experience in performing and interpreting CT pulmonary angiography, the following flowchart approach can be adopted.
Determine chances of PE | |||||||||||||||||||||||||||||||||
Low chance | High chance | ||||||||||||||||||||||||||||||||
D-dimer | |||||||||||||||||||||||||||||||||
<500 ng/ml | >500 ng/ml | CT Pulmonary angiography | |||||||||||||||||||||||||||||||
PE excluded | Negative | Positive | |||||||||||||||||||||||||||||||
PE excluded | PE confirmed | ||||||||||||||||||||||||||||||||
Note: If there is a high clinical suspicion of pulmonary embolism, then anticoagulation can begin with a parenteral agent such as unfractionated heparin during the process of performing the diagnostic studies.
Step 2: Use A Risk-Stratified Approach to Treat the Patient with Pulmonary Embolism
Confirmed PE | |||||||||||||||||||||||||||||||||||||||||||||||
Assess Clinical Stability | |||||||||||||||||||||||||||||||||||||||||||||||
Unstable | Stable | ||||||||||||||||||||||||||||||||||||||||||||||
Blood pressure ≦ 90mm Drop in BP ≧ 40mm for > 15 min | Assess RV function Biomarkers of injury | ||||||||||||||||||||||||||||||||||||||||||||||
Thrombolysis Catheter embolectomy Surgery | No Dysfunction + No injury | Dysfunction + No injury | Dysfunction + Injury | ||||||||||||||||||||||||||||||||||||||||||||
Anticoagulation Early discharge | Anticoagulation Ward admission | Thrombolytics ICU admission | |||||||||||||||||||||||||||||||||||||||||||||
Step 3: Assess Treatment Response and Need for Device Based Therapy
Acute PE confirmed | |||||||||||||||||||||||||||||||||||||||||||||||
Anticoagulation contraindicated ? | |||||||||||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||||||||||
IVC filter | Risk stratification | ||||||||||||||||||||||||||||||||||||||||||||||
Low-risk PE | Submassive PE | Massive PE | |||||||||||||||||||||||||||||||||||||||||||||
Anticoagulation | Anticoagulation | ||||||||||||||||||||||||||||||||||||||||||||||
Assess clinically for evidence of increased severity | |||||||||||||||||||||||||||||||||||||||||||||||
Evidence of shock (SBP <90 mmHg) or respiratory failure | Is thrombolytic contraindicated? | ||||||||||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||||||||||
Surgical emblectomy or catheter based interventions | Hold anticoagulation, give thrombolytics then resume anticoagulations | ||||||||||||||||||||||||||||||||||||||||||||||
Patient shows clinical improvement | |||||||||||||||||||||||||||||||||||||||||||||||
No | Yes | ||||||||||||||||||||||||||||||||||||||||||||||
Surgical emblectomy or catheter based interventions | Continue anticoagulation | ||||||||||||||||||||||||||||||||||||||||||||||